Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1975;52:706-713

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilburn, R. L.
Right arrow Articles by Bennet, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilburn, R. L.
Right arrow Articles by Bennet, C. M.

Circulation, Vol 52, 706-713, Copyright © 1975 by American Heart Association


ARTICLES

Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide

RL Wilburn, A Blaufuss and CM Bennet

Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13.8). Average mean blood pressure while on aggressive therapy with conventional medication was 144 +/- 14 mm Hg; on minoxidil and propranolol it was 108 "/- 10 mm Hg (P less thator to optimum blood pressure control and required large doses of furosemide to control. Propranolol blunted the reflex tachycardia associated with arteriolar dilator therapy but all patients continued with a clinically hyperdynamic circulation. Seven of seven had elevated ejection fractions on echocardiogram, and two of three had elevated cardiac indices. Three of three who had heart catheterization had pulmonary hypertension which was aggravated by exercise. An additional three patients on hydralazine, propranolol, and furosemide also had pulmonary hypertension suggesting this is not unique to minoxidil. Two of thirteen developed pericardial effusions. Renal function improved in three and worsened in three.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
T. Rosenthal, J. Swartz, A. Teicher, and H. Boichis
Minoxidil in the Treatment of Refractory Hypertension
Angiology, March 1, 1980; 31(3): 176 - 184.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
T. Rosenthal, J. Swartz, A. Teicher, and H. Boichis
Minoxidil in the Treatment of Refractory Hypertension
Angiology, February 1, 1980; 31(2): 109 - 119.
[Abstract] [PDF]